Nitrogen-containing bisphosphonate induces enhancement of OPG expression and inhibition of RANKL expression via inhibition of farnesyl pyrophosphate synthase to inhibit the osteogenic differentiation and calcification in vascular smooth muscle cells

被引:0
|
作者
Xu, Wei [1 ,2 ,3 ,4 ]
Gong, Lifeng [2 ,3 ]
Tang, Weigang [2 ,3 ]
Lu, Guoyuan [1 ]
机构
[1] Soochow Univ, Affiliated Hosp 1, Dept Nephrol, Suzhou 215006, Jiangsu, Peoples R China
[2] Xuzhou Med Univ, Jiangsu Key Lab New Drug Res & Clin Pharm, Xuzhou 221004, Jiangsu, Peoples R China
[3] Jiangsu Univ, Dept Nephrol, Wujin Hosp, Changzhou 213000, Jiangsu, Peoples R China
[4] Peoples Hosp Hainan Tibetan Autonomous Prefecture, Dept Nephrol, Qinghai 813099, Hainan, Peoples R China
来源
BMC CARDIOVASCULAR DISORDERS | 2024年 / 24卷 / 01期
关键词
Nitrogen-containing bisphosphonate; Vascular smooth muscle cells; Vascular calcification; OPG; RANKL; Farnesyl pyrophosphate synthase; ZOLEDRONIC ACID; PATHWAY; ALENDRONATE; SYSTEM;
D O I
10.1186/s12872-024-04048-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Nitrogen-containing bisphosphonate(N-BP)had been found to inhibit the osteogenic differentiation and calcification in vascular smooth muscle cells (VSMCs), but the mechanism is not clear. We intend to verify that N-BP induces enhancement of OPG expression and inhibition of RANKL expression via inhibition of farnesyl pyrophosphate synthase(FPPS) to inhibit the osteogenic differentiation and calcification in VSMCs. Methods beta-glycerophosphate (beta-GP) was used to induce the osteogenic differentiation and calcification in VSMCs. VSMCs were treated with N-BP or pretreated with downstream products of farnesyl pyrophosphate synthase(FPPS) in mevalonate pathway, such as farnesol (FOH) or geranylgeraniol (GGOH). Alizarin red S staining and determination of calcium content were used to detect calcium deposition.Western Blotting were used to detect expressions of proteins(OPG and RANKL ) and osteogenic marker proteins (Runx2 and OPN). Results beta-GP induced the osteogenic differentiation and calcification in VSMCs, increased RANKL protein expression and had no significant effect on OPG protein expression. With the treatment of N-BP, the expression of OPG protein was increased and expression of RANKL protein was decreased in VSMCs undergoing osteogenic differentiation and calcification. In addition, N-BP reduced the osteogenic marker proteins (Runx2 and OPN) expression and calcium deposition in VSMCs undergoing osteogenic differentiation and calcification. These effects of N-BP on the osteogenic differentiation and calcification in VSMCs were concentration-dependent, which could be reversed by the downstream products of FPPS, such as FOH or GGOH. Conclusion N-BP increases OPG expression and decreases RANKL expression via inhibition of FPPS to inhibit the osteogenic differentiation and calcification in VSMCs.
引用
收藏
页数:11
相关论文
共 27 条
  • [1] Inhibition of farnesyl pyrophosphate synthase attenuates high glucose-induced vascular smooth muscle cells proliferation
    Chen, Guo-Ping
    Zhang, Xiao-Qin
    Wu, Tao
    Han, Jie
    Ye, Dan
    MOLECULAR MEDICINE REPORTS, 2017, 15 (05) : 3153 - 3160
  • [2] Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced fibrotic responses in vascular smooth muscle cells
    Du, Chang-Qing
    Liu, Xiao-Wei
    Zeng, Guang-Zhong
    Jin, Hong-Feng
    Tang, Li-Jiang
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 35 (06) : 1767 - 1772
  • [3] Inhibition of farnesyl pyrophosphate synthase prevents norepinephrine–induced fibrotic responses in vascular smooth muscle cells from spontaneously hypertensive rats
    Chang-Qing Du
    Lin Yang
    Jian Yang
    Jie Han
    Xiao-Sheng Hu
    Tao Wu
    Shen-Jiang Hu
    Hypertension Research, 2014, 37 : 26 - 34
  • [4] Correlation between time-dependent inhibition of human farnesyl pyrophosphate synthase and blockade of mevalonate pathway by nitrogen-containing bisphosphonates in cultured cells
    Raikkonen, Johanna
    Taskinen, Markku
    Dunford, James E.
    Monkkonen, Hannu
    Auriola, Seppo
    Monkkonen, Jukka
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 407 (04) : 663 - 667
  • [5] Inhibition of farnesyl pyrophosphate synthase prevents norepinephrine-induced fibrotic responses in vascular smooth muscle cells from spontaneously hypertensive rats
    Du, Chang-Qing
    Yang, Lin
    Yang, Jian
    Han, Jie
    Hu, Xiao-Sheng
    Wu, Tao
    Hu, Shen-Jiang
    HYPERTENSION RESEARCH, 2014, 37 (01) : 26 - 34
  • [6] Inhibition of PTEN expression and activity by angiotensin II induces proliferation and migration of vascular smooth muscle cells
    Dong, Xue
    Yu, Lu-Gang
    Sun, Rong
    Cheng, Yan-Na
    Cao, Hua
    Yang, Kang-Min
    Dong, Yi-Ning
    Wu, Yan
    Guo, Xiu-Li
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2013, 114 (01) : 174 - 182
  • [7] Biomechanical stress induces tissue factor expression in vascular smooth muscle cells via RhoA/Rho-Kinase: inhibition by atorvastatin.
    Bavendiek, U
    Kumaravelu, J
    Feurer, M
    Ebensperger, R
    Grote, K
    Schieffer, B
    JOURNAL OF VASCULAR RESEARCH, 2005, 42 : 60 - 60
  • [8] ANG II induces apoptosis of human vascular smooth muscle via extrinsic pathway involving inhibition of Akt phosphorylation and increased FasL expression
    Li, YX
    Song, YH
    Mohler, J
    Delafontaine, P
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2006, 290 (05): : H2116 - H2123
  • [9] Statins inhibit Angiotensin II-induced gene expression in vascular smooth muscle cells via inhibition of tyrosine phosphorylation and protein kinase C (PKC) translocation.
    Abou-Rebyeh, F
    Fiebeler, A
    Lindschau, C
    Luft, FC
    Haller, H
    HYPERTENSION, 2001, 38 (03) : 492 - 492
  • [10] FGV-2 signaling alters vascular smooth muscle cell fate and induces osteogenic marker gene expression via Cbfa1 in rat aortic smooth muscle cells
    Sato, H
    Sato, M
    Kowase, KK
    Oyama, Y
    Iso, T
    Doi, H
    Kanai, H
    Salto, Y
    Ohyama, Y
    Kurabayashi, M
    CIRCULATION, 2003, 108 (17) : 301 - 301